Titan Bio-Tech [TITANBIO] vs OneSource Specialty [ONESOURCE] Detailed Stock Comparison
Titan Bio-Tech
BSE
Loading...
OneSource Specialty
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Titan Bio-Tech wins in 13 metrics, OneSource Specialty wins in 4 metrics, with 0 ties. Titan Bio-Tech appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Titan Bio-Tech | OneSource Specialty | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 35.79 | -1,129.08 | OneSource Specialty |
| Price-to-Book Ratio | 5.13 | 3.58 | OneSource Specialty |
| Debt-to-Equity Ratio | 1.82 | 16.03 | Titan Bio-Tech |
| PEG Ratio | 4.99 | N/A | N/A |
| EV/EBITDA | 30.03 | 32.83 | Titan Bio-Tech |
| Profit Margin (TTM) | 13.76% | -0.85% | Titan Bio-Tech |
| Operating Margin (TTM) | 16.31% | 6.32% | Titan Bio-Tech |
| EBITDA Margin (TTM) | 16.31% | 6.32% | Titan Bio-Tech |
| Return on Equity | 14.04% | -0.31% | Titan Bio-Tech |
| Return on Assets (TTM) | 12.32% | -0.24% | Titan Bio-Tech |
| Free Cash Flow (TTM) | $106.79M | $-1.96B | Titan Bio-Tech |
| Dividend Yield | 0.42% | N/A | N/A |
| 1-Year Return | 33.04% | 5.61% | Titan Bio-Tech |
| Price-to-Sales Ratio (TTM) | 4.93 | 14.24 | Titan Bio-Tech |
| Enterprise Value | $7.85B | $177.48B | OneSource Specialty |
| EV/Revenue Ratio | 4.91 | 11.99 | Titan Bio-Tech |
| Gross Profit Margin (TTM) | 48.49% | 71.61% | OneSource Specialty |
| Revenue per Share (TTM) | $193 | $139 | Titan Bio-Tech |
| Earnings per Share (Diluted) | $26.62 | $-1.07 | Titan Bio-Tech |
| Beta (Stock Volatility) | 0.23 | N/A | N/A |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Titan Bio-Tech vs OneSource Specialty Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Titan Bio-Tech | 1.69% | 7.36% | 37.60% | 123.15% | 104.11% | 26.96% |
| OneSource Specialty | 1.03% | 0.90% | -4.90% | -9.68% | 14.74% | 5.61% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Titan Bio-Tech | 33.04% | 252.87% | 522.82% | 3,129.33% | 2,862.69% | 5,150.95% |
| OneSource Specialty | 5.61% | 5.61% | 5.61% | 5.61% | 5.61% | 5.61% |
News Based Sentiment: Titan Bio-Tech vs OneSource Specialty
Titan Bio-Tech
News based Sentiment: MIXED
September presented a mixed bag for Titan Biotech. While the company showcased impressive revenue growth and financial stability, the insider selling by a promoter raises concerns about confidence in the short-term outlook. This combination of positive and negative signals makes it a significant month for investors to assess the company's trajectory.
OneSource Specialty
News based Sentiment: MIXED
OneSource is undergoing a major transformation with a multi-company merger and significant capacity expansion, which is positive. However, despite substantial revenue growth, profitability remains a major concern, and debt is increasing, creating a mixed investment picture. The strategic shift and financial performance warrant close attention.
Performance & Financial Health Analysis: Titan Bio-Tech vs OneSource Specialty
| Metric | TITANBIO | ONESOURCE |
|---|---|---|
| Market Information | ||
| Market Cap | ₹8.10B | ₹212.56B |
| Market Cap Category | Small cap | Large cap |
| 10 Day Avg. Volume | 31,282 | 235,524 |
| 90 Day Avg. Volume | 32,475 | 155,520 |
| Last Close | ₹968.80 | ₹1,805.90 |
| 52 Week Range | ₹373.65 - ₹1,017.00 | ₹1,209.95 - ₹2,248.00 |
| % from 52W High | -4.74% | -19.67% |
| All-Time High | ₹1,017.85 (Oct 21, 2024) | ₹2,248.00 (Jun 18, 2025) |
| % from All-Time High | -4.82% | -19.67% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.08% | 3.18% |
| Quarterly Earnings Growth | 0.07% | N/A |
| Financial Health | ||
| Profit Margin (TTM) | 0.14% | -0.01% |
| Operating Margin (TTM) | 0.16% | 0.06% |
| Return on Equity (TTM) | 0.14% | 0.00% |
| Debt to Equity (MRQ) | 1.82 | 16.03 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹185.75 | ₹514.02 |
| Cash per Share (MRQ) | ₹6.72 | ₹33.31 |
| Operating Cash Flow (TTM) | ₹197.75M | ₹-2,152,760,000 |
| Levered Free Cash Flow (TTM) | ₹215.32M | ₹-179,710,000 |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.42% | N/A |
| Last 12-Month Dividend | ₹4.00 | N/A |
Valuation & Enterprise Metrics Analysis: Titan Bio-Tech vs OneSource Specialty
| Metric | TITANBIO | ONESOURCE |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 35.79 | -1,129.08 |
| Forward P/E | N/A | 26.87 |
| PEG Ratio | 4.99 | N/A |
| Price to Sales (TTM) | 4.93 | 14.24 |
| Price to Book (MRQ) | 5.13 | 3.58 |
| Market Capitalization | ||
| Market Capitalization | ₹8.10B | ₹212.56B |
| Enterprise Value | ₹7.85B | ₹177.48B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 4.91 | 11.99 |
| Enterprise to EBITDA | 30.03 | 32.83 |
| Risk & Other Metrics | ||
| Beta | 0.23 | N/A |
| Book Value per Share (MRQ) | ₹185.75 | ₹514.02 |
Financial Statements Comparison: Titan Bio-Tech vs OneSource Specialty
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | TITANBIO | ONESOURCE |
|---|---|---|
| Revenue/Sales | ₹464.96M | ₹3.27B |
| Cost of Goods Sold | ₹239.50M | ₹929.19M |
| Gross Profit | ₹225.47M | ₹2.34B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹75.85M | ₹206.81M |
| EBITDA | ₹94.59M | ₹937.52M |
| Pre-Tax Income | ₹81.12M | ₹-43.99M |
| Income Tax | ₹19.51M | ₹-42.13M |
| Net Income (Profit) | ₹68.63M | ₹-1.86M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | TITANBIO | ONESOURCE |
|---|---|---|
| Cash & Equivalents | ₹51.28M | N/A |
| Total Current Assets | ₹790.38M | N/A |
| Total Current Liabilities | ₹177.36M | N/A |
| Long-Term Debt | ₹4.19M | N/A |
| Total Shareholders Equity | ₹1.53B | N/A |
| Retained Earnings | ₹1.36B | N/A |
| Property, Plant & Equipment | ₹571.62M | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | TITANBIO | ONESOURCE |
|---|---|---|
| Operating Cash Flow | ₹45.62M | N/A |
| Capital Expenditures | ₹-33.58M | N/A |
| Free Cash Flow | ₹12.24M | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | TITANBIO | ONESOURCE |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 31,282 | 235,524 |
| Average Daily Volume (90 Day) | 32,475 | 155,520 |
| Shares Outstanding | 8.26M | 114.44M |
| Float Shares | 2.65M | 55.57M |
| % Held by Insiders | 0.67% | 0.41% |
| % Held by Institutions | 0.00% | 0.28% |
Dividend Analysis & Yield Comparison: Titan Bio-Tech vs OneSource Specialty
| Metric | TITANBIO | ONESOURCE |
|---|---|---|
| Last 12-Month Dividend | ₹4.00 | N/A |
| Last 12-Month Dividend Yield | 0.42% | N/A |
| 3-Year Avg Annual Dividend | ₹1.93 | N/A |
| 3-Year Avg Dividend Yield | 0.34% | N/A |
| 3-Year Total Dividends | ₹5.80 | N/A |
| Ex-Dividend Date | Sep 19, 2025 | N/A |